Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners—An Observational, Retrospective, Cross-Sectional Study Using Real-World Data
Abstract
:1. Introduction
2. Patients and Methods
2.1. Study Design
2.2. Statistical Analysis
3. Results
3.1. Survey among Patients
3.2. Survey among General Practitioners
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Kay, L.; Jørgensen, T.; Jensen, K.H. Epidemiology of abdominal symptoms in a random population: Prevalence, incidence, and natural history. Eur. J. Epidemiol. 1994, 10, 559–566. [Google Scholar] [CrossRef] [PubMed]
- Ziółkowski, B.A.; Pacholec, A.; Kudlicka, M.; Ehrmann, A.; Muszyński, J. Prevalence of abdominal symptoms in the Polish population. Gastroenterol. Rev. 2012, 1, 20–25. [Google Scholar] [CrossRef] [Green Version]
- Holtedahl, K.; Vedsted, P.; Borgquist, L.; Donker, G.A.; Buntinx, F.; Weller, D.; Braaten, T.; Hjertholm, P.; Månsson, J.; Strandberg, E.L.; et al. Abdominal symptoms in general practice: Frequency, cancer suspicions raised, and actions taken by GPs in six European countries. Cohort study with prospective registration of cancer. Heliyon 2017, 3, e00328. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Narang, M.; Shah, D.; Akhtar, H. Efficacy and safety of drotaverine hydrochloride in children with recurrent abdominal pain: A randomized placebo controlled trial. Indian Pediatr. 2015, 52, 847–851. [Google Scholar] [CrossRef] [PubMed]
- Narang, S.; Koli, J. Efficacy and safety of fixed-dose combination of drotaverine hydrochloride (80 mg) and paracetamol (500 mg) in amelioration of abdominal pain in acute infectious gastroenteritis: A randomized controlled trial. J. Gastroenterol. Hepatol. 2018, 33, 1942–1947. [Google Scholar] [CrossRef]
- Pareek, A.; Chandurkar, N.B.; Patil, R.T.; Agrawal, S.N.; Uday, R.B.; Tambe, S.G. Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: A double-blind, double-dummy, randomized comparative study with aceclofenac. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010, 152, 86–90. [Google Scholar] [CrossRef] [PubMed]
- Rai, R.; Dwivedi, M.; Kumar, N. Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: A randomized double-blind placebo-controlled study. Saudi J. Gastroenterol. 2014, 20, 378. [Google Scholar] [CrossRef]
- Romics, I.; Molnár, D.L.; Timberg, G.; Mrklic, B.; Jelakovic, B.; Köszegi, G.; Blaskó, G. The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones. BJU Int. 2003, 92, 92–96. [Google Scholar] [CrossRef] [Green Version]
- Csoke, E.; Landes, S.; Francis, M.J.; Ma, L.; Teotico Pohlhaus, D.; Anquez-Traxler, C. How can real-world evidence aid decision making during the life cycle of nonprescription medicines? Clin. Transl. Sci. 2022, 15, 43–54. [Google Scholar] [CrossRef]
- Mehmood, A.; Ur-Rehman, A.; Zaman, M.; Iqbal, J.; Hassan, S.S.U. Self-medication; An Emerging Trend. Br. J. Pharm. Res. 2016, 14, 1–8. [Google Scholar] [CrossRef]
- Eurostat. Self-Reported Use of Non-Prescribed Medicines by Sex, Age and Educational Attainment Level. 2021. Available online: https://ec.europa.eu/eurostat/databrowser/view/hlth_ehis_md2e/default/table?lang=en (accessed on 15 October 2021).
- Panda, A.; Pradhan, S.; Mohapatra, G.; Mohapatra, J. Drug-related problems associated with self-medication and medication guided by prescription: A pharmacy-based survey. Indian J. Pharmacol. 2016, 48, 515. [Google Scholar] [CrossRef] [Green Version]
- Keselman, A.; Browne, A.C.; Kaufman, D.R. Consumer Health Information Seeking as Hypothesis Testing. J. Am. Med. Inform. Assoc. 2008, 15, 484–495. [Google Scholar] [CrossRef]
- Chatila, R.; Merhi, M.; Hariri, E.; Sabbah, N.; Deeb, M.E. Irritable bowel syndrome: Prevalence, risk factors in an adult Lebanese population. BMC Gastroenterol. 2017, 17, 137. [Google Scholar] [CrossRef]
- Orlando, V.; Mucherino, S.; Guarino, I.; Guerriero, F.; Trama, U.; Menditto, E. Gender Differences in Medication Use: A Drug Utilization Study Based on Real World Data. Int. J. Environ. Res. Public Health 2020, 17, 3926. [Google Scholar] [CrossRef]
- Samulowitz, A.; Gremyr, I.; Eriksson, E.; Hensing, G. “Brave Men” and “Emotional Women”: A Theory-Guided Literature Review on Gender Bias in Health Care and Gendered Norms towards Patients with Chronic Pain. Pain Res. Manag. 2018, 2018, 6358624. [Google Scholar] [CrossRef]
- Barraza-Ortiz, D.A.; Pérez-López, N.; Medina-Lópe, V.M.; Minero-Alfaro, J.I.; Zamarripa-Dorsey, F.; Fernández-Martínez, N.D.C.; Llorente-Ramón, A.; Ramos-Aguilar, G.A. Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: A Pilot Study. Dig. Dis. 2021, 39, 294–300. [Google Scholar] [CrossRef]
- Vandvik, P.O.; Kristensen, P.; Aabakken, L.; Farup, P.G. Abdominal complaints in general practice Diagnoses and characteristics of patients. Scand. J. Prim. Health Care 2004, 22, 157–162. [Google Scholar] [CrossRef]
- Rai, R.; Nijhawan, S. Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study. Saudi J. Gastroenterol. 2021, 27, 136–143. [Google Scholar] [CrossRef]
- Xue, X.; Qi, X.X.; Wan, X.Y. Randomized controlled study of efficacy and safety of drotaverine hydrochloride in patients with irritable bowel syndrome. Medicine 2017, 96, e9235. [Google Scholar] [CrossRef]
- Gabhane, M.; Braganza, L. Preference trends for antispasmodics among Indian healthcare professionals: Results of a cross sectional survey. Indian Pract. 2015, 68, 32–37. [Google Scholar]
- Debski, R.; Niemiec, T.; Mazurek, M.; Debska, M. Comparative efficacy and tolerability of drotaverine 80 mg and ibuprofen 400 mg in patients with primary dysmenorrhoea—Protocol DOROTA. Ginekol. Pol. 2007, 78, 933–938. [Google Scholar] [PubMed]
- Marjoribanks, J.; Ayeleke, R.; Farquhar, C.; Proctor, M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst. Rev. 2015, 7, CD001751. [Google Scholar] [CrossRef] [PubMed]
- Hartleb, M.; Mastalerz-Migas, A.; Kowalski, P.; Okopień, B.; Popovic, B.; Proga, K.; Cywińska-Durczak, B. Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: A cross-sectional survey. Eur. J. Gastroenterol. Hepatol. 2022, 34, 426–434. [Google Scholar] [CrossRef] [PubMed]
- Domitrz, I.; Lipa, A.; Rożniecki, J.; Stępień, A.; Kozubski, W. Migraine diagnosis and treatment in Poland: Survey of primary care practitioners. Neurol. Neurochir. Pol. 2021, 55, 380–386. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Eder, P.; Kowalski, P.; Mastalerz-Migas, A.; Skrzydlo-Radomanska, B.; Cichy, W.; Proga, K. Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners—An Observational, Retrospective, Cross-Sectional Study Using Real-World Data. J. Clin. Med. 2022, 11, 3156. https://doi.org/10.3390/jcm11113156
Eder P, Kowalski P, Mastalerz-Migas A, Skrzydlo-Radomanska B, Cichy W, Proga K. Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners—An Observational, Retrospective, Cross-Sectional Study Using Real-World Data. Journal of Clinical Medicine. 2022; 11(11):3156. https://doi.org/10.3390/jcm11113156
Chicago/Turabian StyleEder, Piotr, Piotr Kowalski, Agnieszka Mastalerz-Migas, Barbara Skrzydlo-Radomanska, Wojciech Cichy, and Katarzyna Proga. 2022. "Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners—An Observational, Retrospective, Cross-Sectional Study Using Real-World Data" Journal of Clinical Medicine 11, no. 11: 3156. https://doi.org/10.3390/jcm11113156
APA StyleEder, P., Kowalski, P., Mastalerz-Migas, A., Skrzydlo-Radomanska, B., Cichy, W., & Proga, K. (2022). Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners—An Observational, Retrospective, Cross-Sectional Study Using Real-World Data. Journal of Clinical Medicine, 11(11), 3156. https://doi.org/10.3390/jcm11113156